Showing results (131-140 of 559) with videos related to

Sort By:
Pageof 56
European Heart Journal|January 9, 2017
A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trialChristina L Fanola, Robert P Giugliano, Christian T Ruff, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|September 26, 2013
Circadian variation of stent thrombosis and the effect of more robust platelet inhibition: a post hoc analysis of the TRITON-TIMI 38 trialOwen Mogabgab, Stephen D Wiviott, Christopher P Cannon, et al.
European Heart Journal. Acute Cardiovascular Care|December 25, 2014
Prognostic performance of a high-sensitivity assay for cardiac troponin I after non-ST elevation acute coronary syndrome: Analysis from MERLIN-TIMI 36Marc P Bonaca, Ryan G O'Malley, Sabina A Murphy, et al.
Circulation|March 15, 2006
A tale of two trials: a comparison of the post-acute coronary syndrome lipid-lowering trials A to Z and PROVE IT-TIMI 22Stephen D Wiviott, James A de Lemos, Christopher P Cannon, et al.
American Heart Journal|November 24, 2007
Effect of enoxaparin versus unfractionated heparin in diabetic patients with ST-elevation myocardial infarction in the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) trialDavid A Morrow, Elliott M Antman, Sabina A Murphy, et al.
Journal of the American College of Cardiology|February 18, 2014
Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36)Ryan G O'Malley, Marc P Bonaca, Benjamin M Scirica, et al.
JAMA|September 28, 2016
Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysisMichael G Silverman, Brian A Ference, Kyungah Im, et al.
The American Journal of Cardiology|April 22, 2011
Opposing effects of β blockers and angiotensin-converting enzyme inhibitors on development of new-onset diabetes mellitus in patients with stable coronary artery diseaseOrly Vardeny, Hajime Uno, Eugene Braunwald, et al.
American Heart Journal|August 25, 2009
Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: a TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)-Thrombolysis in Myocardial Infarction (TIMI) 38 substudyYuri B Pride, Stephen D Wiviott, Jacqueline L Buros, et al.
Lancet (London, England)|November 13, 2020
Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trialsBaris Gencer, Nicholas A Marston, KyungAh Im, et al.
Pageof 56